Bifidobacterium animalis, a widely recognized species within the genus Bifidobacterium, is increasingly valued for its role in improving gut health and supporting various physiological functions. As a prominent player in probiotic research, B. animalis has gained attention for its ability to modulate the human microbiome, contributing to better digestive health, immune system support, and even metabolic regulation. This article explores the many facets of B. animalis, from its biological characteristics to its applications in probiotic research and product development.
Fig.1 Colony (left) and cells (right) of B. animalis subsp. lactis.1
B. animalis is a Gram-positive, anaerobic bacterium commonly found in the intestines of humans and animals. It is classified as a probiotic due to its beneficial effects on health. This species is part of the broader Bifidobacterium genus, which includes several species known for their health-promoting properties. B. animalis is further divided into various subspecies, including B. animalis ssp. lactis, which is widely utilized in probiotic formulations. For more information on Gram staining and microbial identification techniques, which are essential for characterizing such bacteria, you can refer to the detailed guide provided by Creative Biolabs.
This subspecies is particularly renowned for its stability and resistance to adverse environmental conditions, making it ideal for use in probiotic products.
A well-documented strain of B. animalis, BB-12 has been extensively researched for its digestive and immune-boosting effects. It is one of the most studied probiotic strains and is commonly found in commercial probiotic supplements and functional foods.
These strains of B. animalis exhibit unique characteristics that set them apart from other probiotic bacteria, such as their ability to adhere to intestinal surfaces, survive gastric acid exposure, and produce beneficial metabolites.
One of the primary benefits of B. animalis is its ability to support digestive health by promoting a balanced gut microbiota. The gut microbiota is a complex ecosystem of microorganisms that plays a crucial role in digestion, nutrient absorption, and immune system regulation. B. animalis helps maintain this balance by outcompeting harmful pathogens and supporting the growth of beneficial bacteria.
Research has shown that B. animalis can alleviate common gastrointestinal issues such as:
In addition to its digestive health benefits, B. animalis plays a critical role in modulating immune responses. The bacterium helps regulate the gut-associated lymphoid tissue (GALT), which is integral to immune system function. By promoting the production of beneficial cytokines and enhancing the gut's barrier function, B. animalis can boost the body's natural defenses against infections and inflammation.
Studies have shown that B. animalis can:
Emerging research suggests that B. animalis may also have a positive impact on metabolic health. Its benefits extend beyond the gut to include regulation of weight, cholesterol levels, and blood sugar. Studies indicate that B. animalis supplementation may:
While the primary focus of B. animalis has been on gut and metabolic health, its benefits may extend to other areas, including:
B. animalis has emerged as a pivotal model organism in probiotic research, owing to its well-documented health benefits, including gut microbiota modulation and immune enhancement. Its ease of cultivation and remarkable survivability in harsh gastrointestinal conditions make it a preferred choice for studying gut health and developing probiotic formulations . Notably, mammalian models (e.g., germ-free mice, humanized microbiota models) play a critical role in evaluating the efficacy and safety of such live biotherapeutic products. For detailed experimental design and assessment methodologies, refer to the guide to mammalian models for live biotherapeutic product assessment .
Clinical trials involving B. animalis have demonstrated its potential in improving gut health, reducing gastrointestinal disorders, and even supporting immune function. Its versatility also makes it ideal for exploring new probiotic applications, such as the gut-brain connection and metabolic health.
There is a growing body of evidence supporting the efficacy of B. animalis as a probiotic. Several clinical studies have shown that it can help improve the symptoms of various gastrointestinal disorders, enhance immune responses, and contribute to overall wellness. In addition to its established benefits in gut health, B. animalis is being explored in clinical settings for its potential to support metabolic health, including weight management and blood sugar regulation.
B. animalis has been the subject of research on the gut-brain axis, which refers to the bidirectional communication between the gut microbiota and the central nervous system. This area of study is crucial for understanding how the microbiome influences mood, cognitive function, and mental health. Preliminary studies suggest that B. animalis may have a positive effect on mental health by regulating the production of neurotransmitters such as serotonin and dopamine.
B. animalis ssp. lactis is a strain often used in the production of probiotic supplements and functional foods. It is known for its resilience to manufacturing processes, such as freeze-drying, and its ability to maintain stability during storage. This strain is commonly found in dairy products and supplements, where it plays a crucial role in supporting gut health.
B. animalis BB-12 is one of the most researched probiotic strains. It has been shown to provide significant benefits for digestive health, including reducing symptoms of IBS, promoting regular bowel movements, and alleviating constipation. BB-12 has also been shown to support immune function, reduce inflammation, and improve overall gut microbiota composition.
For more detailed information of B. animalis strains, you can explore the comprehensive product listings and resources available at Creative Biolabs.
CAT# | Product Name | Description |
---|---|---|
LBST-053FG | Bifidobacterium animalis subsp. lactis; 700541 | B. animalis subsp. lactis was isolated from yogurt. |
LBST-054FG | Bifidobacterium animalis | B. animalis is a Gram-positive, anaerobic, rod-shaped bacterium of the Bifidobacterium genus which can be found in the large intestines of most mammals, including humans. |
LBP-006CYG | Bifidobacterium animalis Powder | Freeze-dried B. animalipowder |
LBP-003FG | Bifidobacterium animalis subsp. lactis Powder | Freeze-dried B. animalis subsp. lactis Powder |
LBGF-0722-GF9 | Bifidobacterium animalis subsp. animalis | A Gram-positive, anaerobic, rod-shaped bacterium of the Bifidobacterium genus which can be found in the large intestines of most mammals, including humans. |
LBGF-0722-GF64 | Bifidobacterium animalis subsp. lactis 420 | Known for its immunoregulatory properties and improving intestinal epithelial integrity in mice models, has been given to humans in earlier clinical trials. |
B. animalis is widely incorporated into various probiotic products, including:
The demand for probiotics, particularly those containing B. animalis, has surged in recent years due to increasing consumer awareness of gut health and its impact on overall well-being. As the health and wellness industry continues to grow, the inclusion of B. animalis in various products is expected to expand.
One promising direction for future research is the development of personalized probiotics tailored to individual microbiomes. As more is understood about the unique gut flora of each person, B. animalis and other probiotics may be customized to address specific health concerns.
Researchers are exploring novel probiotic delivery systems, such as microencapsulation, to protect B. animalis during digestion and improve its efficacy in reaching the intestines. Additionally, the development of combination probiotics that combine B. animalis with other beneficial strains may offer enhanced health benefits.
References
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.